Evaluation of Customized Treatment According to BRCA1 Assessment in Patients With Advanced Gastric Cancer
Evaluation of customized treatment according to BRCA1 assessment in patients with advanced gastric cancer
Advanced Gastric Cancer
DRUG: FLOT Regimen|DRUG: FLO Regimen or FLOT Regimen
Progression-free Survival, 12 months
Overall Survival, 12 months|Response Rate, 12 months
Evaluation of customized treatment according to BRCA1 assessment in patients with advanced gastric cancer